Vivekanand Cotspin IPO
Vivekanand Cotspin IPO is an SME IPO raising ₹24 Cr at ₹32 – ₹37 a share. It listed on 28 Sept 2026 at ₹38, +2.7% against its issue price of ₹37, and trades at ₹41 today (+10.8% since issue). It was subscribed 1.73× in total.
Just covered — bids slightly exceed the shares on offer
populated partly populated we hold nothing here — the tab says why
The numbers at a glance
The price they’re asking →derived: cut-off price Rs37 / stated EPS Rs2.45 (FY26 (year ended March 31, 2026) Basic and Diluted EPS, based on Restated Financial Statements). Stated figures are as printed in the prospectus; margins, growth and the borrowing ratio are computed from its own summary table. A multiple is one lens, not a verdict.
The last few years in numbers
From the prospectus’s own summary financial table (Restated Standalone). Margins and growth are computed from the stated figures; everything else is as printed.
| Period | Revenue | Profit after tax | PAT margin | Net worth | Borrowings |
|---|---|---|---|---|---|
| Period ended March 31, 2025 | ₹290 Cr | ₹4 Cr | 1.4% | ₹17 Cr | ₹55 Cr |
| Period ended August 04, 2024 | ₹75 Cr | ₹1 Cr | 1.2% | ₹23 Cr | ₹33 Cr |
| FY ended March 31, 2026 | ₹408 Cr | ₹4 Cr | 0.9% | ₹29 Cr | ₹45 Cr |
| FY ended March 31, 2024 | ₹357 Cr | ₹3 Cr | 0.9% | ₹21 Cr | ₹40 Cr |
How its cohort has done
185 SME issues listed in 2026 that we can price today. This is the group this issue belongs to.
Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →
How the book finished
The category split is the number worth reading, not the total.
Demand is spread fairly evenly across investor categories.
What we hold for this issue
Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.
What could go wrong
All 13 risks & documents →From the register read out of the issuer’s own prospectus — each item is quoted verbatim with its page on the risks tab.
What happens when
Next: the UPI mandate expires on 4 Nov 2026.
What to watch
- Priced at 15.1× earnings — 5% below the median of the peers the issuer itself names.
- The register's top risk: Related-party revenue concentration to Ambica Cotseeds (prospectus page 25).
- Its cohort's record: median −2.7% since issue price, 51.9% now below it — a base rate, not a forecast.
Each line restates a disclosure from the prospectus or the exchanges — nothing here is a recommendation to apply to this issue.
Track VIVEKANAND COTSPIN LIMITED
Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.
Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.